GlaxoSmithKline Intellectual Property Development Limited
发明人:
Anderson, Niall Andrew,Barton, Nicholas Paul,Campos, Sebastien Andre,Cannons, Edward Paul,Cooper, Anthony William James,Down, Kenneth David,Doyle, Kevin James,Hamblin, Julie Nicole,Inglis, Graham Geor
申请号：
AU2017218530
公开号：
AU2017218530A1
申请日:
2017.02.10
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The invention is directed to certain novel compounds. Specifically, the invention is directed to compounds of formula (I): (I) and salts thereof. The compounds of the invention are inhibitors of kinase activity, in particular PI3- kinase activity.
